HemoSense
INRatio training module launched for U.S. distribution partners
Published in Lab Business Week, October 9th, 2005
The EOL-1 module offers health industry distributor representatives an interactive, web-based tool for accessing mandatory educational information on patients taking Coumadin (warfarin), a blood-thinning drug, and the INRatio system.
Warfarin patients must monitor the effectiveness of their therapy through regular PT/INR testing in order to guard against potentially lethal blood clots. The INRatio system measures a patient's blood-clotting time with one drop of blood from a fingerstick, giving...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2005-10-09)
More Articles from Lab Business Week
- Access Pharmaceuticals
Targeted drug delivery company reports status of convertible notes - Alexion Pharmaceuticals, Inc.
Vikas Sinha named senior VP and CFO for cardiovascular drug maker - Algeta ASA
Cancer drug developer raises EUR 23 million in series A round - Amicus Therapeutics
Pharmacological chaperone developer raises $55M in financing - Anadys Pharmaceuticals
Pharmaceutical company names member to board of directors - Ascentia Biomedical Corp.
Cancer drug developer receives $1M funding commitment - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
